GEORGIEV; Ivelin

Patent Applications and Registrations

Patent applications and USPTO patent grants for GEORGIEV; Ivelin.The latest application filed is for "therapeutic antibodies for treating lung cancer".

Company Profile

8.9.13

GEORGIEV; Ivelin - Nashville TN
Georgiev; Ivelin - Gaithersburg MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic Antibodies For Treating Lung Cancer App 20220185911 - KRAMER; Kevin J. ; et al.	2022-06-16
Neutralizing Antibodies To Hiv-1 Gp41 And Their Use App 20220098286 - Kwong; Peter ; et al.	2022-03-31
Neutralizing antibodies to HIV-1 GP41 and their use Grant 11,236,152 - Kwong , et al. February 1, 2	2022-02-01
Self-assembling Insect Ferritin Nanoparticles App 20210198324 - Kwong; Peter ; et al.	2021-07-01
Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens Grant 10,961,283 - Kwong , et al. March 30, 2	2021-03-30
Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein Grant 10,815,295 - Kwong , et al. October 27, 2	2020-10-27
Recombinant Hiv-1 Envelope Proteins And Their Use App 20190389915 - Kwong; Peter ; et al.	2019-12-26
Self-assembling Insect Ferritin Nanoparticles For Display Of Co-assembled Trimeric Antigens App 20190330279 - Kwong; Peter ; et al.	2019-10-31
Recombinant HIV-1 envelope proteins and their use Grant 10,400,015 - Kwong , et al. Sep	2019-09-03
Neutralizing Antibodies To Hiv-1 Gp41 And Their Use App 20190077849 - Kwong; Peter ; et al.	2019-03-14
Broadly Neutralizing Hiv-1 Antibodies That Bind To The Cd4-binding Site Of The Envelope Protein App 20190016786 - Kwong; Peter D. ; et al.	2019-01-17
Neutralizing GP41 antibodies and their use Grant 10,047,148 - Connors , et al. August 14, 2	2018-08-14
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein Grant 10,035,844 - Kwong , et al. July 31, 2	2018-07-31
Neutralizing Gp41 Antibodies And Their Use App 20180002406 - Connors; Mark ; et al.	2018-01-04
Neutralizing GP41 antibodies and their use Grant 9,783,595 - Connors , et al. October 10, 2	2017-10-10
Neutralizing Antibodies To Hiv-1 And Their Use App 20170267748 - Kwong; Peter D. ; et al.	2017-09-21
Recombinant Hiv-1 Envelope Proteins And Their Use App 20170233441 - Kwong; Peter ; et al.	2017-08-17
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein Grant 9,695,230 - Kwong , et al. July 4, 2	2017-07-04
Neutralizing Gp41 Antibodies And Their Use App 20160333076 - Connors; Mark ; et al.	2016-11-17
Neutralizing GP41 antibodies and their use Grant 9,475,862 - Connors , et al. October 25, 2	2016-10-25
Neutralizing Gp41 Antibodies And Their Use App 20140348785 - Connors; Mark ; et al.	2014-11-27
Neutralizing Antibodies To Hiv-1 And Their Use App 20140322163 - Kwong; Peter D. ; et al.	2014-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.